av/acrivon-therapeutics--big.svg

COM:ACRIVON

Acrivon

  • Stock

Last Close

6.44

22/11 21:00

Market Cap

221.08M

Beta: -

Volume Today

25.35K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
550K
-
934K
69.82%
2.98M
218.63%
average receivables
book value per share
-0.65
-
-1.84
182.43%
0.04
102.24%
0.01
86.73%
capex per share
-0.00
-
-0.02
1,483.45%
-0.00
97.15%
-0.00
88.90%
capex to depreciation
-1.15
-
-6.43
457.48%
-5.95
7.49%
0.46
107.77%
capex to operating cash flow
0.01
-
0.02
218.08%
0.07
322.51%
0.03
58.00%
capex to revenue
cash per share
0.12
-
7.72
6,179.28%
0.03
99.60%
0.01
81.37%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.03
-
0.05
98.92%
0.03
48.16%
0.03
22.70%
debt to equity
-0.01
-
-0.24
3,328.75%
0.03
112.31%
0.04
31.67%
dividend yield
earnings yield
-41.18K
-
-125.82K
205.50%
-0.00
100.00%
-0.00
11.05%
enterprise value
-1.52M
-
-93.97M
6,062.81%
47.46B
50,602.72%
108.59B
128.81%
enterprise value over ebitda
0.48
-
5.82
1,104.17%
-1.45K
25,070.68%
-1.62K
11.36%
ev to operating cash flow
0.54
-
6.72
1,135.47%
-1.58K
23,546.20%
-2.55K
61.61%
ev to sales
free cash flow per share
-0.22
-
-1.10
403.59%
-0.01
99.29%
-0.00
74.60%
free cash flow yield
-21.87K
-
-110.15K
403.59%
-0.00
100.00%
-0.00
40.52%
graham net net
-0.70
-
-2.39
240.88%
0.03
101.19%
0.00
82.39%
graham number
2.46
-
7.23
193.74%
0.08
98.87%
0.02
77.55%
income quality
0.53
-
0.86
62.95%
0.97
12.26%
0.71
26.93%
intangibles to total assets
0
-
0
0
0
interest coverage
21.92
-
interest debt per share
0.00
-
0.44
9,583.77%
0.00
99.81%
0.00
75.02%
inventory turnover
invested capital
-0.01
-
-0.24
3,328.75%
0.03
112.31%
0.04
31.67%
market cap
128.84
-
129.10
0.20%
47.48B
36,781,624,435.05%
108.62B
128.76%
net current asset value
-8.88M
-
-29.99M
237.74%
117M
490.16%
112.62M
3.74%
net debt to ebitda
0.48
-
5.82
1,104.07%
0.75
87.08%
0.47
37.83%
net income per share
-0.41
-
-1.26
205.50%
-0.01
99.43%
-0.00
62.01%
operating cash flow per share
-0.22
-
-1.08
397.81%
-0.01
99.33%
-0.00
73.57%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-2.43
-
-0.15
93.72%
-0.16
7.46%
-0.44
166.71%
revenue per share
roe
0.63
-
0.68
8.17%
-0.17
125.52%
-0.50
186.22%
roic
0.38
-
1.29
240.02%
-0.17
113.37%
-0.51
198.34%
sales general and administrative to revenue
shareholders equity per share
-0.65
-
-1.84
182.43%
0.04
102.24%
0.01
86.73%
stock based compensation to revenue
tangible asset value
-8.41M
-
-23.81M
183.00%
170.47M
816.01%
121.19M
28.91%
tangible book value per share
-0.65
-
-1.84
182.43%
0.04
102.24%
0.01
86.73%
working capital
1.11M
-
97.49M
8,715.01%
121.23M
24.35%
116.39M
4.00%

All numbers in (except ratios and percentages)